HonorHealth's cancer research program at the Research Institute is an international powerhouse because its top scientists focus endless energy on one mission: curing cancer. The program is changing how the world treats cancer through the development of new cancer drugs and fast-tracking their FDA approval.
As a leader in clinical research, HonorHealth's program gives you access to clinical trials from phase I to phase IV, with a special focus in early drug development. You could benefit from:
In fact, if you're a newly diagnosed patient in the HonorHealth Virginia G. Piper Cancer Care Network, you'll be screened to see if you qualify for a clinical trial. A trial is an option at any stage of your cancer journey. You don't have to wait until other treatments have failed to enroll in a trial. You'll be joining cancer patients from across Arizona and the U.S., and from other countries.
Each clinical trial has specific eligibility criteria — requirements you have to meet before you can participate. Your clinical trials navigator will help you make a decision.
Since its launch in 2005, HonorHealth's cancer research program has established strong partnerships with leading universities, nonprofit organizations and medical device and drug companies. HonorHealth's remarkable achievements in cancer research include: